Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Asset Writedowns and Impairment (2020 - 2025)

Aspen Aerogels (ASPN) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with -$2000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment fell 100.03% year-over-year to -$2000.0, compared with a TTM value of $281.5 million through Sep 2025, up 3673.0%, and an annual FY2024 reading of $247000.0, changed N/A over the prior year.
  • Asset Writedowns and Impairment was -$2000.0 for Q3 2025 at Aspen Aerogels, down from $288.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $288.1 million in Q2 2025 and bottomed at -$6.6 million in Q4 2024.
  • Average Asset Writedowns and Impairment over 5 years is $19.3 million, with a median of $4000.0 recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 2575.0% in 2023, then surged 35915.12% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $15000.0 in 2021, then soared by 386.67% to $73000.0 in 2022, then tumbled by 235.62% to -$99000.0 in 2023, then plummeted by 6519.19% to -$6.6 million in 2024, then soared by 99.97% to -$2000.0 in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for ASPN at -$2000.0 in Q3 2025, $288.1 million in Q2 2025, and -$100000.0 in Q1 2025.